AMBRILIA BIOPHARMA Trademark

Trademark Overview

On Friday, April 7, 2006, a trademark application was filed for AMBRILIA BIOPHARMA with the United States Patent and Trademark Office. The USPTO has given the AMBRILIA BIOPHARMA trademark a serial number of 78856449. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Monday, April 4, 2011. This trademark is owned by Ambrilia Biopharma Inc.. The AMBRILIA BIOPHARMA trademark is filed in the Pharmaceutical Products, Treatment & Processing of Materials Services, and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceutical preparations for the treatment of cancer and infectious diseases

Manufacturing services for others in the field of therapeutic and diagnostic products

Pharmaceutical research and development in the field of therapeutic and diagnostic products
ambrilia biopharma

General Information

Serial Number78856449
Word MarkAMBRILIA BIOPHARMA
Filing DateFriday, April 7, 2006
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateMonday, April 4, 2011
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Indication of Colors claimedColor is not claimed as a feature of the mark.
Disclaimer with Predetermined Text"BIOPHARMA"
Goods and ServicesPharmaceutical preparations for the treatment of cancer and infectious diseases
Goods and ServicesManufacturing services for others in the field of therapeutic and diagnostic products
Goods and ServicesPharmaceutical research and development in the field of therapeutic and diagnostic products

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, April 12, 2006
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class040 - Treatment of materials.
US Class Codes100, 103, 106
Class Status Code6 - Active
Class Status DateFriday, January 5, 2007
Primary Code040
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, April 12, 2006
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAmbrilia Biopharma Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressVerdun, Quebec Prov HeE 1H4
CA

Trademark Events

Event DateEvent Description
Monday, April 4, 2011ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Monday, April 4, 2011ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Thursday, August 19, 2010NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Thursday, August 19, 2010INQUIRY TO SUSPENSION E-MAILED
Thursday, August 19, 2010SUSPENSION INQUIRY WRITTEN
Tuesday, August 10, 2010LIE CHECKED SUSP - TO ATTY FOR ACTION
Friday, January 29, 2010NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Friday, January 29, 2010LETTER OF SUSPENSION E-MAILED
Friday, January 29, 2010SUSPENSION LETTER WRITTEN
Friday, January 29, 2010TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, January 29, 2010CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, January 27, 2010TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, January 27, 2010TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Tuesday, August 25, 2009NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Tuesday, August 25, 2009INQUIRY TO SUSPENSION E-MAILED
Tuesday, August 25, 2009SUSPENSION INQUIRY WRITTEN
Friday, August 14, 2009LIE CHECKED SUSP - TO ATTY FOR ACTION
Monday, February 9, 2009NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Monday, February 9, 2009LETTER OF SUSPENSION E-MAILED
Monday, February 9, 2009SUSPENSION LETTER WRITTEN
Friday, January 23, 2009LIE CHECKED SUSP - TO ATTY FOR ACTION
Friday, January 23, 2009LIE CHECKED SUSP - TO ATTY FOR ACTION
Wednesday, July 16, 2008NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Wednesday, July 16, 2008LETTER OF SUSPENSION E-MAILED
Wednesday, July 16, 2008SUSPENSION LETTER WRITTEN
Friday, July 11, 2008LIE CHECKED SUSP - TO ATTY FOR ACTION
Friday, January 11, 2008NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Friday, January 11, 2008LETTER OF SUSPENSION E-MAILED
Friday, January 11, 2008SUSPENSION LETTER WRITTEN
Thursday, January 10, 2008TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, January 10, 2008CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, January 8, 2008TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Tuesday, October 30, 2007TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, July 24, 2007NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Tuesday, July 24, 2007INQUIRY TO SUSPENSION E-MAILED
Tuesday, July 24, 2007SUSPENSION INQUIRY WRITTEN
Wednesday, July 18, 2007LIE CHECKED SUSP - TO ATTY FOR ACTION
Tuesday, January 16, 2007LETTER OF SUSPENSION E-MAILED
Tuesday, January 16, 2007SUSPENSION LETTER WRITTEN
Friday, January 5, 2007TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, January 5, 2007CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, January 5, 2007ASSIGNED TO LIE
Thursday, November 30, 2006TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, June 1, 2006NON-FINAL ACTION E-MAILED
Thursday, June 1, 2006NON-FINAL ACTION WRITTEN
Thursday, June 1, 2006ASSIGNED TO EXAMINER
Thursday, April 13, 2006NOTICE OF DESIGN SEARCH CODE MAILED
Wednesday, April 12, 2006NEW APPLICATION ENTERED IN TRAM

Related Keywords

biopharma ambrilia therapeutic field pharmaceutical diagnostic products development research others services treatment